TY - JOUR
T1 - Prevalence of Hidradenitis Suppurativa in Athens, Greece
T2 - A Cross-Sectional Study Based on a Validated Questionnaire
AU - Kanni, Theodora
AU - Ktena, Sofia
AU - Leventogiannis, Konstantinos
AU - Damoulari, Christina
AU - Bouazzi, Dorra
AU - Medianfar, Cecilia E.
AU - Christensen, Robin
AU - Jemec, Gregor B.E.
AU - Giamarellos-Bourboulis, Evangelos J.
N1 - Publisher Copyright:
© 2025 The Author(s). Published by S. Karger AG, Basel.
PY - 2025
Y1 - 2025
N2 - UNLABELLED: Introduction: Prevalence of hidradenitis suppurativa (HS) differs between countries and the worldwide prevalence of the disease remains unknown. Prevalence of HS has never been studied in Greece. The aim of this study was to estimate the HS prevalence in Athens, the capital of Greece.METHOD: Healthy adults accompanying patients to the outpatient department of internal medicine of ATTIKON University Hospital were approached by physicians familiar with HS. All eligible persons signed an informed consent form and answered the questionnaire. This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative and therefore followed the objective and approach previously published by Bouazzi et al. [Dermatology. 2024 Feb;240(3):369-75].RESULTS: Out of 553 participants, 20 screened positive for HS. Of these, only one was diagnosed with HS, resulting in a prevalence of 0.18% (95% CI, 0.03%-1.02%). The sensitivity of the HS questionnaire was 100%, specificity 75.9%, positive predictive value 5.0%, and negative predictive value 100%.CONCLUSION: The prevalence of HS in our study was relatively low. A further study with a larger number of participants is needed to confirm the findings. .
AB - UNLABELLED: Introduction: Prevalence of hidradenitis suppurativa (HS) differs between countries and the worldwide prevalence of the disease remains unknown. Prevalence of HS has never been studied in Greece. The aim of this study was to estimate the HS prevalence in Athens, the capital of Greece.METHOD: Healthy adults accompanying patients to the outpatient department of internal medicine of ATTIKON University Hospital were approached by physicians familiar with HS. All eligible persons signed an informed consent form and answered the questionnaire. This study was a part of the Global Hidradenitis Suppurativa Atlas (GHiSA) initiative and therefore followed the objective and approach previously published by Bouazzi et al. [Dermatology. 2024 Feb;240(3):369-75].RESULTS: Out of 553 participants, 20 screened positive for HS. Of these, only one was diagnosed with HS, resulting in a prevalence of 0.18% (95% CI, 0.03%-1.02%). The sensitivity of the HS questionnaire was 100%, specificity 75.9%, positive predictive value 5.0%, and negative predictive value 100%.CONCLUSION: The prevalence of HS in our study was relatively low. A further study with a larger number of participants is needed to confirm the findings. .
KW - Athens
KW - Hidradenitis suppurativa
KW - Outpatient department
KW - Prevalence
KW - University hospital
KW - Greece/epidemiology
KW - Cross-Sectional Studies
KW - Humans
KW - Middle Aged
KW - Hidradenitis Suppurativa/epidemiology
KW - Male
KW - Young Adult
KW - Adult
KW - Female
KW - Surveys and Questionnaires
KW - Aged
UR - https://www.scopus.com/pages/publications/105010577952
U2 - 10.1159/000539758
DO - 10.1159/000539758
M3 - Journal article
C2 - 40623410
AN - SCOPUS:105010577952
SN - 1018-8665
VL - 241
SP - 1
EP - 5
JO - Dermatology
JF - Dermatology
IS - Suppl. 1
ER -